|
Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
|
06 April 2011 |
|
Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective
|
30 March 2011 |
|
Sanofi-aventis Strengthens Commitment to Ophthalmology through Partnership with The Vision Institute
|
24 March 2011 |
|
Sanofi Pasteur and International Vaccine Institute Partner against Dengue
|
23 February 2011 |
|
Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right
|
17 February 2011 |
|
Sanofi-aventis' fourth-quarter and full-year net sales
|
10 February 2011 |
|
European Commission Clears Acquisition of Genzyme Corporation by sanofi-aventis
|
17 January 2011 |
|
Sanofi-aventis Acquires from Ascendis Pharma Worldwide Rights on Drug-Delivery Technology
|
22 December 2010 |
|
Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
|
08 November 2010 |
|
Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development
|
04 November 2010 |